Analystreport

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $38.00 price target on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report